Overview
- 21 inspections across 20 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
21
Sites
20
Observations
5
Career since
Jul 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shanghai Henlius Biopharmaceuticals Co., Ltd. | 20 May 2026 | Human Drugs | On file |
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) | 15 Dec 2025 | Human Drugs | On file |
| Eli Lilly & Company | 20 May 2025 | Human Drugs | View 483 → |
| FUJIFILM Diosynth Biotechnologies Texas, LLC | 11 Mar 2025 | Human Drugs | On file |
| Allergan Pharmaceuticals Ireland | 30 Jan 2025 | Human Drugs | On file |
Sites inspected
Shanghai Henlius Biopharmaceuticals Co., Ltd.Shanghai, China1 insp.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)Nanjing, China1 insp.
Eli Lilly & CompanyIndianapolis, United States1 insp.
FUJIFILM Diosynth Biotechnologies Texas, LLCCollege Station, United States1 insp.
Allergan Pharmaceuticals IrelandWestport, Ireland1 insp.
Co-investigators
Investigators who share inspections with this person.
Debra M Emerson3 shared
Zhong Li2 shared
Carl A Perez2 shared
Sharmila Shrestha2 shared
Anthony F Lorenzo2 shared
Randa Melhem2 shared
Xiaoshi Wang1 shared
Jiangsong Jiang1 shared
Scott D Mcgrew1 shared
Kara J Wright1 shared
Full investigator report
Get the verbatim findings behind Jie He's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site